Evidence map›Paper›PMID 37404372›Full record

ArticleiScience2023

Muscle glycome in idiopathic inflammatory myopathies: Impact in IL-6 production and disease prognosis.

Ana Campar, Inês Alves, Beatriz Santos-Pereira, Rafaela Nogueira, Miguel Mendonça Pinto, Carlos Vasconcelos, Salomé S Pinho

Open access · goldAbstract read
In one paragraph

Article in iScience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Ana CamparInstitute for Research and Innovation in Health (i3S), University of Porto, Porto, Portugal.
Inês AlvesInstitute for Research and Innovation in Health (i3S), University of Porto, Porto, Portugal.
Beatriz Santos-PereiraInstitute for Research and Innovation in Health (i3S), University of Porto, Porto, Portugal.
Rafaela NogueiraInstitute for Research and Innovation in Health (i3S), University of Porto, Porto, Portugal.
Miguel Mendonça PintoNeuropathology Department, Porto University Hospital Centre, Porto, Portugal.
Carlos VasconcelosClinical Immunology Unit, Porto University Hospital Centre, Porto, Portugal.
Salomé S PinhoInstitute for Research and Innovation in Health (i3S), University of Porto, Porto, Portugal.
CUF Porto Hospital · PTi3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto · PTUniversidade do Porto · PTUniversidade Nova de Lisboa · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Idiopathic inflammatory myopathies (IIM) are a group of chronic autoimmune diseases mainly affecting proximal muscles. Absence of meaningful prognostic factors in IIM has hindered new therapies development. Glycans are essential molecules that regulate immunological tolerance and consequently the onset of autoreactive immune response. We showed that muscle biopsies from patients with IIM revealed a deficiency in the glycosylation pathway resulting in loss of branched

Indexed as

DiseaseGlycobiologyGlycomicsHealth sciences

Identifiers

PMID37404372
PMCPMC10316658
OpenAlexW4381094076

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.